PharSQ® BASE DS 47

1 of 17 products in this brand
PharSQ® BASE DS 47 is a pharmaceutical and nutraceutical ingredient primarily known for its buffering agent function. It is available in the form of crystals and is chemically identified as Sodium phosphate dibasic heptahydrate. This product falls within the category of excipients used in pharmaceutical and nutraceutical formulations. This product complies with the standards set by the United States Pharmacopeia (USP), ensuring its quality and suitability for various applications in the healthcare and dietary supplement industries.

Supplied By: Budenheim

Product Code: P00054

Regional Availability: Canada

Chemical Name: Sodium phosphate dibasic heptahydrate

Functions: Buffering Agent

CAS Number: 7782-85-6

Labeling Claims: Allergen-free, Animal Products-free, BSE-free, GMO-free, Halal, Kosher, Vegan, Vegetarian

    Enhanced TDS

    Identification & Functionality

    Chemical Name
    Sodium phosphate dibasic heptahydrate
    Country of Origin
    Germany
    Ingredient Origin
    Mineral Origin
    Supplied By
    Budenheim
    Pharma & Nutraceuticals Functions
    Buffering Agent
    CAS No.
    7782-85-6
    EC No.
    616-512-8
    Technologies
    Pharmaceuticals & Nutraceuticals
    Product Families
    Pharmaceuticals & Nutraceuticals — Excipients
    Formulation & Processing Aids

    Features & Benefits

    Labeling Claims
    Allergen-free,
    Animal Products-free,
    BSE-free,
    GMO-free,
    Generally Recognized As Safe (GRAS),
    Halal,
    Kosher,
    Residual Solvent -Free,
    TSE-free,
    Vegan,
    Vegetarian
    Product Highlights
    • The aqueous solution of Disodium Phosphate heptahydrate has an alkaline action. In addition, Disodium Phosphate heptahydrate has excellent buffering qualities.
    • Due to its physical properties and the content of water of hydration, Disodium Phosphate heptahydrate strongly tends to form lumps and should therefore be further processed soon after receipt.
    • The strong lump formation tendency generally increases over time of storage, especially when the material is exposed to high temperature, high humidity levels or high pressure.
    • These lump formations might be reversible through an adequate physical treatment of the material.

    Applications & Uses

    Markets
    Healthcare & Pharma
    Applications
    Healthcare & Pharma — Pharmaceutical Manufacturing
    Excipients & Coatings,
    Pharmaceutical Processing
    Segments
    Pharmaceuticals
    Applications
    Pharmaceuticals — Excipients
    Application Information

    Buffers/ Synthesis

    Properties

    Physical Form
    Crystals,
    Powder,
    Solid
    Notes

    ¹ .All values provided are approximate and not part of the specification.
    ². Internal test method at 25°C

    Regulatory & Compliance

    Certifications & Compliance
    FDA 21 CFR 182.6285,
    Regulation (EU) No. 1169/2011,
    United States Pharmacopeia (USP)

    Packaging & Availability

    Packaging Type
    Bag
    Regional Availability
    • Canada
    Packaging Information
    • 25 kg PE bags with UV-sealing valve
    • On CP1 pallet, PE stretch wrap foil, 17 μm

    Storage & Handling

    Shelf Life
    2 years
    Storage Condition

    Store at room temperature in protected areas and in well closed containers. As storage conditions, we recommend peak temperatures being below 30°C and the relative humidity being constantly below 65%.